Cite
In Silico Evaluation of Human Cathelicidin LL-37 as a Novel Therapeutic Inhibitor of Panton-Valentine Leukocidin Toxin of Methicillin-Resistant Staphylococcus aureus .
MLA
Toor, Himanshu G., et al. “In Silico Evaluation of Human Cathelicidin LL-37 as a Novel Therapeutic Inhibitor of Panton-Valentine Leukocidin Toxin of Methicillin-Resistant Staphylococcus Aureus .” Microbial Drug Resistance (Larchmont, N.Y.), vol. 27, no. 5, May 2021, pp. 602–15. EBSCOhost, https://doi.org/10.1089/mdr.2020.0196.
APA
Toor, H. G., Banerjee, D. I., & Chauhan, J. B. (2021). In Silico Evaluation of Human Cathelicidin LL-37 as a Novel Therapeutic Inhibitor of Panton-Valentine Leukocidin Toxin of Methicillin-Resistant Staphylococcus aureus . Microbial Drug Resistance (Larchmont, N.Y.), 27(5), 602–615. https://doi.org/10.1089/mdr.2020.0196
Chicago
Toor, Himanshu G, Devjani I Banerjee, and Jenabhai B Chauhan. 2021. “In Silico Evaluation of Human Cathelicidin LL-37 as a Novel Therapeutic Inhibitor of Panton-Valentine Leukocidin Toxin of Methicillin-Resistant Staphylococcus Aureus .” Microbial Drug Resistance (Larchmont, N.Y.) 27 (5): 602–15. doi:10.1089/mdr.2020.0196.